Loading asset research
Apnimed Inc. Common Stock
APMDNasdaq · USD · StocksQuote as of · Exchange session not verified$26.32
-1.79%
Today
APMD
Loading 1D prices…
Market cap
$1.1B
Volume
207.8K
52w high
$35.2952w low
$16.12Company profile
Apnimed Inc. Common Stock
Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. It offers AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Cambridge, MA, United States
Employees
81
Fiscal year end
1231
CIK
1745648
Session & valuation
Open$27.07
Previous close$26.80
Day high$27.72
Day low$26.19
30-day avg. volume464.4K
Outstanding shares41.6M
Diluted EPS-$0.03
Latest annual period
P/E (trailing)4.59
P/E (forward)-6.60
Price / book-0.49
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| SVRASavara Inc. Common Stock | $1.1B | $0.00 | — | -$0.53 | -0.28% | Buy |
| CRVSCorvus Pharmaceuticals Inc. Common Stock | $1.1B | $0.00 | — | -$0.53 | -0.23% | Buy |
| OBXObsidian Therapeutics Inc. Common Stock | $1.1B | $0.00 | — | -$1.63 | +4.72% | Buy |
| MLTXMoonLake Immunotherapeutics Class A Ordinary Shares | $1.1B | $0.00 | — | -$3.53 | -5.14% | Buy |
| JBIOJade Biosciences Inc. Common Stock | $1.1B | $0.00 | — | -$3.19 | -6.84% | Buy |